Clinical Trials
1st Edition
Will be published approx. on 4. December 2001
Book
Paperback/Softback
144 pages
978-0-7279-1599-3 (ISBN)
Description
This authoritative book discusses the use of clinical trials in health sciences including why they are important, how to do them and how they can be used most relevantly in health care for the future.
The chapters are based on papers given at an Oxford seminar by leading figures in this field and the discussions that followed.
The book will be of particular interest to clinical trialists and the pharmaceutical industry.
The chapters are based on papers given at an Oxford seminar by leading figures in this field and the discussions that followed.
The book will be of particular interest to clinical trialists and the pharmaceutical industry.
More details
Language
English
Place of publication
United States
Publishing group
John Wiley & Sons Inc
Target group
College/higher education
Professional and scholarly
Dimensions
Height: 218 mm
Width: 140 mm
Thickness: 9 mm
Weight
191 gr
ISBN-13
978-0-7279-1599-3 (9780727915993)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Lelia Duley is an Obstetric Epidemiologist at the Institute of Health Sciences in Oxford, UK.
Content
Contributors. Foreword.
Preface.
Acknowledgements.
Comparing like with like and the development of randomisation.
Why we need randomised controlled trials.
Keeping track of trial reports; the experience of The Cochrane Trials Register.
What have we learned from 50 years of randomised trials for people with schizophrenia.
Big is still beautiful: why we still need large simple trials.
Factors that limit the number, quality and progress of randomised trials.
The nuts and bolts of doing trials.
Building resources for randomised trials.
The role of data monitoring committees.
Bayesian perspectives on the ethics of trials.
"Empowering" patient choice about participation in trials?.
Index
Preface.
Acknowledgements.
Comparing like with like and the development of randomisation.
Why we need randomised controlled trials.
Keeping track of trial reports; the experience of The Cochrane Trials Register.
What have we learned from 50 years of randomised trials for people with schizophrenia.
Big is still beautiful: why we still need large simple trials.
Factors that limit the number, quality and progress of randomised trials.
The nuts and bolts of doing trials.
Building resources for randomised trials.
The role of data monitoring committees.
Bayesian perspectives on the ethics of trials.
"Empowering" patient choice about participation in trials?.
Index